![]() |
市場調査レポート
商品コード
1519453
医療機器アウトソーシング市場レポート:サービス、治療薬、用途、地域別、2024年~2032年Medical Device Outsourcing Market Report by Service, Therapeutics, Application, and Region 2024-2032 |
||||||
カスタマイズ可能
|
医療機器アウトソーシング市場レポート:サービス、治療薬、用途、地域別、2024年~2032年 |
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2~3営業日
|
世界の医療機器アウトソーシング市場規模は2023年に1,262億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに2,582億米ドルに達し、2024年から2032年の間に8.1%の成長率(CAGR)を示すと予測しています。医療費全体の削減ニーズの高まり、厳しい規制要件や品質基準の導入、ウェアラブル医療機器の採用拡大、個別化医療に対する需要の急増などが、市場成長を促す主な要因となっています。
医療機器のアウトソーシングとは、医療機器製品のライフサイクルのさまざまな側面を処理するために、外部の企業やサービスプロバイダーと契約または提携することを指します。これらの外部パートナーは通常、専門の受託製造業者、設計開発会社、規制コンサルタント、ロジスティクス・プロバイダー、または医療機器業界に精通したその他のサービス・プロバイダーです。このようなサービスは、コスト削減、専門知識へのアクセス、業務効率の向上、より効果的に市場の需要に適応する能力など、いくつかのメリットを企業に提供します。また、医療機器メーカーは、研究開発、マーケティング、戦略立案などのコアコンピタンスに集中する一方で、製品ライフサイクルのその他の重要な側面を処理するために外部パートナーの能力を活用することができます。
同市場は、医療疾患の増加や質の高いヘルスケアサービスに対するニーズの高まりにより、大きな成長を遂げています。加えて、アウトソーシングは医療機器メーカーに、市場の需要に応じて生産量を拡大できる柔軟性を提供します。この適応性は、製品需要の変動、特に季節変動のある機器や予期せぬ市場の変化に対応するために不可欠です。さらに、個別化医療に対する需要の急増、ウェアラブル医療機器の採用拡大、低侵襲外科手術の人気の高まり、在宅医療、遠隔医療、医療ツーリズムの傾向の高まりは、市場を推進しているその他の要因の一部です。また、国際的な事業を展開する受託製造業者は、多様な市場へのアクセスを提供し、輸出入規制を回避することができるため、新たな地域へのスムーズな進出が容易になり、市場の成長に影響を与えています。
医療費削減ニーズの高まり
医療機器のアウトソーシングは、ヘルスケアプロバイダーや医療機器企業にコスト削減をもたらします。専門メーカーやサービスプロバイダーと契約することで、社内でオペレーションを維持するよりもコスト効率が高まる。外部パートナーは確立された生産設備、スケールメリット、合理化されたプロセスを持っているため、より低コストで医療機器を生産することができます。さらに、製造や物流などの非中核業務をアウトソーシングすることで、医療機器メーカーは資源配分を最適化することができます。定型的な業務を外部のパートナーに任せることで、企業は社内のリソースを研究開発やイノベーションといったコアコンピタンスに集中させることができ、より費用対効果の高い競争力のある製品を生み出すことができます。
厳しい規制要件と品質基準の導入
厳しい規制の導入は、医療機器企業とそのアウトソーシング・パートナーの双方に、より高いコンプライアンス負担を強いることになります。委託製造業者は、OEMと同じ規制基準を遵守し、製造する医療機器が要求される安全性と品質の基準を満たすようにしなければならないです。そのためには、厳格な文書化、品質管理システム、適正製造規範(GMP)の遵守が必要となります。さらに、規制当局の監視が厳しくなるにつれ、医療機器のアウトソーシング・プロセスでは品質保証が最重要課題となっています。受託製造業者は現在、製造プロセスにおける潜在的な問題を特定し、軽減するための強固な品質管理対策とリスク管理戦略の実施を迫られています。
ウェアラブル医療機器の採用拡大
ウェアラブル医療機器には、高度なセンサー、ワイヤレス接続、高度なデータ分析機能が組み込まれていることが多いです。このような技術集約型機器の開発・製造には、専門的な知識とリソースが必要となるため、高度なエレクトロニクスやソフトウェア開発に精通したアウトソーシング・パートナーの需要が高まっています。さらに、医療機器はユーザーのコンプライアンスと長期的な装着性を確保するため、軽量で快適、人間工学的に設計されている必要があります。小型化技術や材料選択に関する専門知識を持つ製造委託先は、こうした設計要件を実現する上で重要な役割を果たしています。
The global medical device outsourcing market size reached US$ 126.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 258.2 Billion by 2032, exhibiting a growth rate (CAGR) of 8.1% during 2024-2032. The rising need to reduce overall medical costs, the implementation of stringent regulatory requirements and quality standards, the expanding adoption of wearable medical devices, and the surging demand for personalized medicine are among the key factors driving the market growth.
Medical device outsourcing refers to the practice of contracting or partnering with external companies or service providers to handle various aspects of the medical device product lifecycle. These external partners are typically specialized contract manufacturers, design and development firms, regulatory consultants, logistics providers, or other service providers with expertise in the medical device industry. These services offer several benefits to companies, including cost savings, access to specialized expertise, increased operational efficiency, and the ability to adapt to market demands more effectively. It also allows medical device manufacturers to concentrate on core competencies, such as research and development, marketing, and strategic planning, while leveraging the capabilities of external partners to handle other essential aspects of the product lifecycle.
The market is experiencing significant growth due to the increasing prevalence of medical ailments and the surging need for quality healthcare services. In addition, outsourcing offers medical device companies the flexibility to scale production volumes based on market demand. This adaptability is essential for managing fluctuations in product demand, especially for devices with seasonal variations or in response to unexpected market shifts. Moreover, the surging demand for personalized medicine, the expanding adoption of wearable medical devices, the growing popularity of minimally invasive surgical procedures, and the rising trend of home healthcare, telemedicine, and medical tourism are some of the other factors propelling the market. Besides, contract manufacturers with international operations can provide access to diverse markets and navigate import/export regulations, facilitating a smoother expansion into new regions and influencing the market growth.
The rising need to reduce overall medical costs
Medical device outsourcing offers cost savings to healthcare providers and medical device companies. Contracting with specialized manufacturers or service providers is more cost-efficient than maintaining in-house operations. External partners have established production facilities, economies of scale, and streamlined processes, enabling them to produce medical devices at lower costs. Moreover, outsourcing non-core activities, such as manufacturing and logistics, allows medical device companies to optimize resource allocation. By delegating routine tasks to external partners, companies can focus their internal resources on core competencies like research, development, and innovation, which can lead to more cost-effective and competitive products.
The implementation of stringent regulatory requirements and quality standards
The implementation of stringent regulations places a higher compliance burden on both medical device companies and their outsourcing partners. Contract manufacturers must adhere to the same regulatory standards as the OEMs to ensure that the medical devices they produce meet the required safety and quality benchmarks. This requires rigorous documentation, quality management systems, and adherence to good manufacturing practices (GMP). Moreover, with higher regulatory scrutiny, quality assurance becomes paramount in the medical device outsourcing process. Contract manufacturers are now under pressure to implement robust quality control measures and risk management strategies to identify and mitigate potential issues in the production process.
The expanding adoption of wearable medical devices
Wearable medical devices often incorporate advanced sensors, wireless connectivity, and sophisticated data analytics capabilities. The development and manufacturing of such technology-intensive devices require specialized expertise and resources, leading to an increased demand for outsourcing partners with expertise in advanced electronics and software development. Moreover, medical devices need to be lightweight, comfortable, and ergonomically designed to ensure user compliance and long-term wearability. Contract manufacturers with expertise in miniaturization techniques and materials selection play a crucial role in achieving these design requirements.
IMARC Group provides an analysis of the key trends in each segment of the global medical device outsourcing market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on service, therapeutics and application.
Regulatory Consulting
Product Design and Development
Product Testing and Sterilization
Product Implementation
Product Upgrade
Product Maintenance
Product design and development represent the leading segment
The report has provided a detailed breakup and analysis of the market based on the service. This includes regulatory consulting, product design and development, product testing and sterilization, product implementation, product upgrade, and product maintenance. According to the report, product design and development represented the largest segment.
Medical device design and development requires a high level of technical expertise, including knowledge of regulatory requirements, engineering principles, and medical standards. Many medical device companies lack in-house capabilities or resources to handle the complex design process efficiently. Outsourcing product design and development allows them to tap into the specialized expertise of experienced design firms and engineering companies with a proven track record in the medical device industry. Moreover, outsourcing product design and development enables medical device companies to access fresh ideas, creative solutions, and cutting-edge technologies from external design partners.
Cardiology
Diagnostic Imaging
Orthopedic
IVD
Ophthalmic
General and Plastic Surgery
Drug Delivery
Dental
Endoscopy
Diabetes Care
Cardiology exhibits a clear dominance in the market
A detailed breakup and analysis of the market based on therapeutics have also been provided in the report. This includes cardiology, diagnostic imaging, orthopedic, IVD, ophthalmic, general and plastic surgery, drug delivery, dental, endoscopy, and diabetes care. According to the report, cardiology accounted for the largest market share.
Cardiovascular diseases (CVDs) remain one of the leading causes of death worldwide. The increasing prevalence of conditions such as coronary artery disease, heart failure, and arrhythmias has led to a rising demand for innovative medical devices and technologies to diagnose, treat, and manage these conditions. This high demand has driven medical device companies to focus extensively on cardiology-related products and services, leading to a dominant presence in the outsourcing market. Besides, the field of cardiology has witnessed rapid technological advancements and continuous innovation. These innovations include implantable devices such as pacemakers, defibrillators, stents, and heart valves, as well as diagnostic devices like electrocardiograms (ECGs) and cardiac imaging equipment. To keep up with the pace of innovation and meet market demands, medical device companies often seek specialized outsourcing partners with expertise in cardiology product development.
Class I
Class II
Class III
Class II accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes class I, II, and III. According to the report, class II represented the largest segment.
Class II medical devices encompass a wide range of products, including moderate to high-risk devices that do not fall into the highest-risk Class III category. This broad product range includes items such as infusion pumps, diagnostic imaging equipment, electrocardiographs, surgical instruments, and certain implantable devices. The diversity of Class II devices contributes to a larger market share in the outsourcing industry. Moreover, these medical devices are subject to intermediate levels of regulatory scrutiny compared to Class III devices. While Class II devices must still meet strict regulatory requirements for safety and efficacy, the regulatory process is generally less burdensome and time-consuming than that for Class III devices, which is escalating their demand.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Asia Pacific exhibits a clear dominance, accounting for the largest medical device outsourcing market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Latin America (Mexico, Brazil, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); and Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others). According to the report, Asia Pacific was the largest market for medical device outsourcing.
Asia Pacific countries, such as China, India, and Southeast Asian nations, offer a significant cost advantage in terms of labor and manufacturing. The lower labor costs, combined with well-developed manufacturing infrastructure and supply chain networks, make the region an attractive option for medical device companies seeking cost-effective outsourcing solutions. Moreover, the region boasts a large pool of skilled and trained professionals in engineering, science, and technology fields. This skilled workforce includes engineers, scientists, and technicians with expertise in medical device design, development, and manufacturing. The availability of such talent accelerates the outsourcing process and ensures high-quality products.
The competitive landscape of the medical device outsourcing market is highly dynamic with numerous companies offering a wide range of outsourcing services to medical device manufacturers. Nowadays, key players are expanding their service portfolios to provide a comprehensive range of outsourcing solutions. They are diversifying their offerings to include contract manufacturing, product design and development, regulatory support, post-market services, packaging, and logistics. Companies are also engaging in mergers, acquisitions, and strategic partnerships to expand their geographical presence and technical capabilities. They are also investing heavily in advanced manufacturing technologies such as automation, robotics, 3D printing, and data analytics to improve production efficiency, reduce costs, and offer faster turnaround times to medical device manufacturers.
Celestica Inc. (Onex Corporation)
Charles River Laboratories International Inc.
Flex Ltd.
Freyr Inc.
Heraeus Holding GmbH
ICON plc
Integer Holdings Corporation
IQVIA Inc.
Plexus Corp.
Sanmina Corporation
TE Connectivity
West Pharmaceutical Services Inc.
Flex Ltd. launched "Healthcare Solutions," a comprehensive suite of medical device design, engineering, and manufacturing services. The offering includes rapid prototyping, miniaturization expertise, and end-to-end solutions to support medical device companies throughout the product lifecycle.
Celestica acquired PCI Limited, a provider of design and manufacturing services for medical and other industries. This acquisition strengthened Celestica's presence in the medical device outsourcing market and expanded its offerings in the Asia Pacific region.
Celestica Inc. acquired Atrenne Integrated Solutions, a provider of electronic manufacturing and design services for the aerospace, defense, and other industries. This acquisition enhanced Celestica's capabilities in serving the medical device market.